Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 25, 2022
Ajinomoto Bio-Pharma Services announced that Tony O'Neill has joined Aji Bio-Pharma as Vice President of Compliance, US Operations. Mr. O'Neill brings extensive experience leading Quality, Manufacturing, and Operational Excellence Teams in the ...
read more
Tuesday, January 25, 2022
Sharp has completed the construction of new purpose-built production suites to facilitate the packaging, storage and distribution of gene therapies, at its facility in Heerenveen, The Netherlands.
read more
Tuesday, January 25, 2022
Mindset Pharma Inc. has entered into a pharmaceutical manufacturing agreement with a leading contract development and manufacturing organization (CDMO), for the production of pharmaceutical grade batches of Mindset’s next-generation psilocybin drug ...
read more
Tuesday, January 25, 2022
The project will include the construction of five new laboratories: two of which will be dedicated to research and development; a scale-up chemical synthesis laboratory; as well as Quality Control and analytical services laboratories. All work is due...
read more
Tuesday, January 25, 2022
Catalent announced that it has completed a $10 million expansion in state-of-the-art large-scale isolator units at its Malvern, Pennsylvania, and Dartford, U.K., facilities, to provide advanced containment capabilities for the micronization of highly...
read more
Wednesday, January 26, 2022
Aceto has consolidated and integrated its six manufacturing-related acquisitions to achieve a hybrid manufacturing/distribution model providing key benefits to its customers in high-growth end markets including pharmaceuticals, biopharmaceuticals, ...
read more
Wednesday, January 26, 2022
Recro Pharma has been awarded a new formulation development and cGMP manufacturing contract from a key department of the United States government. The contract focuses on supporting clinical development of a topical dermal treatment for the ...
read more
Wednesday, January 26, 2022
Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading global provider of bio-pharmaceutical contract development and manufacturing services, is pleased to announce that Tony O’Neill has joined Aji Bio-Pharma as Vice President of Compliance, US ...
read more
Thursday, January 27, 2022
Medidata, a Dassault Systèmes company, announced a partnership with Circuit Clinical, an Integrated Research Organization (IRO). Circuit Clinical has created a network representing over 90 doctors, across 30+ site locations, and a nationally ...
read more
Thursday, January 27, 2022
Atara Biotherapeutics, Inc. has entered into a long term strategic agreement with FUJIFILM Diosynth Biotechnologies (FDB), a subsidiary of FUJIFILM Corporation under which Fujifilm will acquire Atara’s T-Cell Operations and Manufacturing (ATOM) ...
read more
Thursday, January 27, 2022
Cryoport, Inc. has entered into a strategic partnership with Cell Matters, S.A. to deliver to the life sciences industry end-to-end cryopreservation services for leukapheresis derived therapies supporting both autologous and allogeneic cell therapies...
read more
Thursday, January 27, 2022
Charles River Laboratories International, Inc. has announced the expansion of their strategic partnership with Chicago, Illinois-based SAMDI Tech, Inc. Under the existing partnership, established in 2018, SAMDI Tech clients have access to Charles ...
read more
Inotiv, Inc. announced that the company has completed the purchase of Orient BioResource Center, Inc. (“OBRC”), from Orient Bio, Inc., a preclinical contract research organization and animal model supplier based in Seongnam, South Korea. Orient ...
read more
Alcami announced a $10 million investment to expand its laboratory operation in Durham, North Carolina. The investment adds over 6700 ft² to the existing laboratory footprint, new equipment, and capabilities to enhance drug substance and drug product...
read more
After one year of re-construction, the new facilities in close proximity to Coriolis’ headquarters in Martinsried will significantly increase Coriolis’ capabilites for ATMP development. Formulation development for ATMPs, including cell culture ...
read more